Avanafil 100 mg tablet |
Company |
Formulation ID |
FDA Description |
VIVUS
|
F02102
|
Calcium carbonate; Fumaric acid; Magnesium stearate; Mannitol; Ferric oxide yellow; Hydroxypropyl cellulose (type h) |
Mist Pharmaceuticals
|
F02103
|
Calcium carbonate; Fumaric acid; Magnesium stearate; Mannitol; Ferric oxide yellow; Hydroxypropyl cellulose, unspecified; Low-substituted hydroxypropyl cellulose (11% hydroxypropyl 130000 mw) |
------------------------------------------------------------------------------------ |
|
|
|
Avanafil 200 mg tablet |
Company |
Formulation ID |
FDA Description |
VIVUS
|
F02104
|
Calcium carbonate; Fumaric acid; Magnesium stearate; Mannitol; Ferric oxide yellow; Hydroxypropyl cellulose (type h) |
Mist Pharmaceuticals
|
F02105
|
Calcium carbonate; Fumaric acid; Magnesium stearate; Mannitol; Ferric oxide yellow; Hydroxypropyl cellulose, unspecified; Low-substituted hydroxypropyl cellulose (11% hydroxypropyl 130000 mw) |
------------------------------------------------------------------------------------ |
|
|
|
Avanafil 50 mg tablet |
Company |
Formulation ID |
FDA Description |
VIVUS
|
F02106
|
Calcium carbonate; Fumaric acid; Magnesium stearate; Mannitol; Ferric oxide yellow; Hydroxypropyl cellulose (type h) |
Mist Pharmaceuticals
|
F02107
|
Calcium carbonate; Fumaric acid; Magnesium stearate; Mannitol; Ferric oxide yellow; Hydroxypropyl cellulose, unspecified; Low-substituted hydroxypropyl cellulose (11% hydroxypropyl 130000 mw) |
------------------------------------------------------------------------------------ |
|
|
|